InsiderTrades

TZIANABOS ARTHUR

SEC CIK 1586226 · EDGAR

Buying vs selling by month open-market trades, last 57 months, all 2 companies
BoughtSold

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
STOKStoke Therapeutics, Inc.Interim Executive COB, Dir 31.3K — $174.2K 32024-02-132026-03-10
QTTBQ32 Bio Inc.Pres, CEO, Dir 8,248 — $48.8K 82022-01-012024-03-25

Most active insiders at STOK, 12 months

#InsiderTitleBoughtSold
1 Krainer Adrian R.Dir —$3.90M
2 Kaye Edward M. MDDir —$3.18M
3 Ticho BarryChief MEDICAL Off —$1.98M
4 Allan JonathanGC, CORP SEC —$1.56M
5 TZIANABOS ARTHURInterim Executive COB, Dir —$174.2K
6 Leggett ThomasCFO —$147.1K
7 Hoitt JasonChief Patient Off —$119.3K
8 LEVIN ARTHUR ADir —$22.3K

Transactions 11

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
D 2026-03-12 2026-03-10 STOK Stoke Therapeutics, Inc. TZIANABOS ARTHUR Interim Executive COB, Dir S - Sale+OE $40.00 -4,355 31.3K -12% -$174.2K
D 2026-03-12 2026-03-10 STOK Stoke Therapeutics, Inc. TZIANABOS ARTHUR Interim Executive COB, Dir M - OptEx $8.33 +3,955 35.7K +12% +$32.9K
D 2024-08-14 2024-03-25 QTTB Q32 Bio Inc. TZIANABOS ARTHUR Dir M - OptEx — +1,095 8,248 +15% —
D 2024-08-14 2024-03-25 QTTB Q32 Bio Inc. TZIANABOS ARTHUR Dir S - Sale+OE $24.20 -265 7,983 -3% -$6,413
D 2024-02-15 2024-02-13 STOK Stoke Therapeutics, Inc. TZIANABOS ARTHUR Dir M - OptEx $2.19 +31.7K 31.7K New +$69.5K
DMT 2024-02-15 2024-01-01 QTTB Q32 Bio Inc. TZIANABOS ARTHUR Dir M - OptEx — +33.4K 122.7K +37% —
DT 2024-02-15 2024-01-09 QTTB Q32 Bio Inc. TZIANABOS ARTHUR Dir S - Sale+OE $0.57 -13.0K 128.8K -9% -$7,431
2023-01-11 2023-01-09 QTTB Q32 Bio Inc. TZIANABOS ARTHUR Dir S - Sale $1.39 -10.6K 108.4K -9% -$14.8K
DM 2023-01-04 2023-01-01 QTTB Q32 Bio Inc. TZIANABOS ARTHUR Dir M - OptEx — +33.0K 119.0K +38% —
D 2022-01-12 2022-01-01 QTTB Q32 Bio Inc. TZIANABOS ARTHUR Pres, CEO, Dir M - OptEx — +13.9K 91.4K +18% —
D 2022-01-12 2022-01-05 QTTB Q32 Bio Inc. TZIANABOS ARTHUR Pres, CEO, Dir S - Sale+OE $3.78 -5,354 86.0K -6% -$20.2K

Purchase Sale Sale after option exercise All abbreviations